- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
6
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
6 companies
AstraZeneca
Market Cap: UK£204.9b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£132.10
7D
-5.7%
1Y
22.7%
Gilead Sciences
Market Cap: US$162.8b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$127.57
7D
-4.6%
1Y
16.7%
Chugai Pharmaceutical
Market Cap: JP¥12.2t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,423.00
7D
-5.8%
1Y
-0.4%
Orion Oyj
Market Cap: €9.5b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€68.05
7D
-4.5%
1Y
10.7%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥38.1b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥84.56
7D
-6.1%
1Y
-12.2%
Xiamen Amoytop Biotech
Market Cap: CN¥22.5b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥55.11
7D
-0.7%
1Y
-26.4%